February 3, 2021
United States Attorney Robert K. Hur announced today that he will resign his position as the chief federal law enforcement officer for the District of Maryland. The U.S. Attorney’s Office for the District of Maryland is one of the country’s largest and busiest, serving a population of more than six million. Mr. Hur will return to private law practice. Jonathan F. Lenzner, who has served as the First Assistant U.S. Attorney during Mr. Hur’s tenure, will become the Acting U.S. Attorney upon his departure.
Mr. Hur took office on April 9, 2018. He tendered his resignation to the President and the Acting Attorney General today, and will conclude his service as United States Attorney on February 15, 2021.
Live Updates: Impeachment Managers Call Trump Singularly Responsible for Riot
nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
Pandemic watchdog probes Mnuchin, Cruz roles in Fed lending
americanbanker.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanbanker.com Daily Mail and Mail on Sunday newspapers.
Technavio Research: Apiculture Market Research 2021-2025|Evolving Opportunities with Apiaries 8, and Apiculture Remuaux|Technavio
Technvaio forecast the global apiculture market is expected to grow by USD 1.08 billion during 2021-2025 as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of over 2%.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210201005866/en/
Technavio has announced its latest market research report titled Global Apiculture Market 2021-2025 (Graphic: Business Wire)
The future of inspections under FDA’s COVID-19 PREPP initiative (MRI).
On January 13, FDA published a summary report on the agency’s Pandemic Recovery and Preparedness Plan (PREPP) initiative, which was launched internally in April 2020 and announced publicly in August 2020. According to the summary report, the PREPP initiative is aimed at strengthening FDA’s ongoing COVID-19 response and building the agency’s resilience to respond to future emergencies, including by identifying several “broad cross-cutting ‘Action Areas’ that reflect ongoing and potential prospective actions.” Notably, these action areas include “continu[ing] to evolve and optimize inspectional operations, building on the COVID-19 experience as a catalyst” and “strengthen[ing] supply chain surveillance for regulated products,” suggesting that several of FDA’s COVID-related inspection pilot projects will continue into the future.